Showing results (11-20 of 230) with videos related to
Sort By:
Pageof 23
International Journal of Psychiatry in Clinical Practice|June 17, 2014
The importance of long-term tolerability in achieving recoveryDavid S BaldwinHuman Psychopharmacology|January 4, 2012
A neuroimmunological perspective on anxiety disordersRuihua Hou, David S BaldwinThe British Journal of Psychiatry : the Journal of Mental Science|June 5, 2013
Antidepressant drugs and sexual dysfunctionDavid S Baldwin, Thomas FoongThe International Journal of Neuropsychopharmacology|December 4, 2004
Evidence-based pharmacotherapy of Generalized Anxiety DisorderDavid S Baldwin, Claire PolkinghornCNS Spectrums|February 25, 2009
The pharmacologic treatment of patients with generalized anxiety disorder: where are we now and where are we going?David S Baldwin, Nupur TiwariNeuropsychiatric Disease and Treatment|March 21, 2009
Role of pregabalin in the treatment of generalized anxiety disorderDavid S Baldwin, Khalil AjelModern Trends in Pharmacopsychiatry|September 17, 2014
Pharmacotherapy of generalized anxiety disorderChrister Allgulander, David S BaldwinThe International Journal of Social Psychiatry|July 9, 2021
A critical review of the definition of 'wellbeing' for doctors and their patients in a post Covid-19 eraGemma Simons, David S BaldwinTherapeutic Advances in Psychopharmacology|August 4, 2020
Clinical characteristics and unlicensed applications of licensed psychotropic drugs within a regional tertiary service for patients with affective disordersNupur Tiwari, David S BaldwinTherapeutic Advances in Psychopharmacology|September 24, 2024
Incorporation of a specialist mental health clinical pharmacist within a primary care network: patient referrals, prescribing decisions, and clinical outcomesRebecca Henry, David S BaldwinPageof 23